Home / 510(k) Clearances / K981314

510(k) K981314

VISUALINE II (ALSO KNOWN AS SUNLINE) METHADONE by Sun Biomedical Laboratories, Inc. — Product Code DJR

K981314 is an FDA 510(k) premarket notification submitted by Sun Biomedical Laboratories, Inc. for the device "VISUALINE II (ALSO KNOWN AS SUNLINE) METHADONE". The FDA issued a decision of Substantially Equivalent on September 4, 1998. The device falls under product code DJR (Enzyme Immunoassay, Methadone), a Class II device regulated under 21 CFR 862.3620. Sun Biomedical Laboratories, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 4, 1998
Date Received
April 10, 1998
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Immunoassay, Methadone
Device Class
Class II
Regulation Number
862.3620
Review Panel
TX
Submission Type

Other clearances by Sun Biomedical Laboratories, Inc.

  • K023856 — VISUALINE METHADONE DIPSTRIPTEST (August 25, 2003)
  • K023648 — VISUALINE CUP IV FOR DRUGS OF ABUSE TEST FOR QUALITATIVE DETERMINATION OF COCAIN (May 6, 2003)
  • K014089 — VISUALINE II (ALSO KNOWN AS SUNLINE) BARITURATES (April 25, 2002)
  • K020136 — VISUALINE BARBITURATES DIPSTRIP TEST (March 20, 2002)
  • K011499 — VISUALINE AMPHETAMINE DIPSTRIP ASSAY (July 17, 2001)
  • K010177 — VISUALINE II (ALSO KNOWN AS SUNLINE) AMPHETAMINE ASSAY (May 17, 2001)
  • K993485 — VISUALINE V DRUGS OF ABUSE DIPSTRIP PANEL FOR QUALITATIVE DETERMINATION OF COCAI (December 27, 1999)
  • K983790 — VISUALINE II (ALSO KNOWN AS SUNLINE) PHENCYCLIDINE (March 1, 1999)
  • K972032 — VISUALINE II METHAMPHETIMINE (August 12, 1997)
  • K963606 — VISUALINE COMBO V (COCAINE/THC) TEST (October 30, 1996)

Other clearances for product code DJR

  • K192433 — LZI Methadone II Enzyme Immunoassay (October 4, 2019)
  • K182779 — ARK EDDP Assay (November 21, 2018)
  • K170416 — LZI Methadone Metabolite Enzyme Immunoassay, LZI Methadone Metabolite (100 and 3 (June 26, 2017)
  • K160793 — First Sign Drug of Abuse Dip Card Test (MDMA, EDDP, Nortriptyline), First Sign D (August 17, 2016)
  • K152025 — AssureTech Buprenorphine Tests (Strip, Panel Dip, Quick Cup, Turn-Key Split Cup) (October 5, 2015)
  • K151395 — Immunalysis EDDP Specific Urine Enzyme Immunoassay, Immunalysis EDDP Urine Calib (July 24, 2015)
  • K151441 — First Sign Drug of Abuse Dip Card Test, First Sign Drug of Abuse Cup Test (June 29, 2015)
  • K131232 — WONDFO METHADONE URINE TEST (MTD 200), WONDOFO MORPHINE URINE TEST (MOP 100) (May 31, 2013)
  • K092272 — RANDOX METHADONE ASSAY (November 18, 2010)
  • K092258 — RANDOX METABOLITE (EDDP) ASSAY (November 9, 2010)

FDA data resources